Overview

Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study is a randomized Trastuzumab-controlled double-blind parallel-group study.
Phase:
Phase 1
Details
Lead Sponsor:
Meiji Seika Pharma Co., Ltd.
Collaborators:
Dong-A
Dong-A Pharmaceutical
Treatments:
Trastuzumab